Miki Ben-Dor
Président chez Rimonyx Pharmaceuticals Ltd.
Provenance du réseau au premier degré de Miki Ben-Dor
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Rimonyx Pharmaceuticals Ltd.
 Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel
5
| Private Company | Pharmaceuticals: Major | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Miki Ben-Dor via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Weizmann Institute of Science | College/University | Undergraduate Degree Corporate Officer/Principal | |
| National Institute on Drug Abuse | General Government | Corporate Officer/Principal | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
| The Salk Institute for Biological Studies | College/University | Corporate Officer/Principal | |
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | ||
| W WORL | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Serono Corp. | Director/Board Member | ||
Sealantium Medical Ltd.
 Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Medical Specialties | Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 6 |
| Israël | 4 |
Sectorielle
| Consumer Services | 3 |
| Government | 3 |
| Health Technology | 3 |
Opérationnelle
| Corporate Officer/Principal | 6 |
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Founder | 2 |
| Undergraduate Degree | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Paul Gregor | 7 |
| Orgad Laub | 4 |
| Regina Zhuk | 1 |
| Alan Lewis | 1 |
| Stanley Hirsch | 1 |
- Bourse
- Insiders
- Miki Ben-Dor
- Connexions Sociétés
